Cat:GMP-h-ACE2-hFc
Awaiting product image
* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry
SKU GMP-h-ACE2-hFc Categories ,

For more than 100mg, click here for inquiry. >>

Product Details

Genemedi produces core diagnostic ingredients for test of Lung injury (acute respiratory distress syndrome) and related syndrome. GeneMedi offers paired diagnostics grade Human Angiotensin Converting Enzyme 2 (ACE2/hFc) antibodies (monoclonal antibody, mab) and antigens for Lung injury (acute respiratory distress syndrome) rapid test kit of Human Angiotensin Converting Enzyme 2 (ACE2/hFc) testing in standard substance, positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. All the antibodies and antigens for Lung injury (acute respiratory distress syndrome ) test are suitable for in functional ELISA, and other immunoassays in dignostics.The antibodies can act as a capture antibody and detection antibody. The antigens can be used as positive control.Angiotensin-converting enzyme 2 (ACE2) is an enzyme that can be found either attached to the membrane of cells (mACE2) in the intestines, kidney, testis, gallbladder, and heart or in a soluble form (sACE2). Both membranes bound and soluble ACE2 are integral parts of the renin–angiotensin–aldosterone system (RAAS) that exists to maintain the body’s blood pressure. As a transmembrane protein, mACE2 serves as the main entry point into cells for some coronaviruses, including HCoV-NL63, SARS-CoV and SARS-CoV-2. The binding of the SARS-CoV-2 virus through mACE2 receptors present in heart tissue may be responsible for direct viral injury leading to myocarditis. human ACE2 (rhACE2) is surmised to be a novel therapy for acute lung injury, and appeared to improve pulmonary blood flow and oxygen saturation in piglets with a lipopolysaccharide-induced acute respiratory distress syndrome

Product Description

Cat No. of Pruducts

GMP-h-ACE2-hFc-Ag01:Recombinant Human ACE2/hFc Protein

Product Name

Recombinant Human ACE2/hFc Protein

Target

Human Angiotensin Converting Enzyme 2

Alias of Target/Biomarker

ACEH

Expression platform

E.coli

Isotypes

Recombinant Antigen

Bioactivity validation

Human Angiotensin Converting Enzyme 2 (ACE2/hFc) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in ACE2/hFc level test of Lung injury (acute respiratory distress syndrome) and related syndrome evaluation

Tag

His

Products description

Recombinant Human ACE2/hFc Protein was expressed in E.coli -based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.

Reconized/Reactive Species

Human

Purity

Purity: ≥95% (SDS-PAGE)

Application

Standard substance, positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT.

Formulation

Supplied as a 0.2 μM filtered solution of PBS,PH7.4.

Storage

Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.
Genemeidi Omicron Variant Products
test
Previous slide
Next slide

Cat No. of Pruducts

GMP-h-ACE2-hFc-Ab01,GMP-h-ACE2-hFc-Ab02:Anti-Human ACE2/hFc mouse monoclonal antibody (mAb)

Product Name

Anti-Human ACE2/hFc mouse monoclonal antibody (mAb)

Target

Alias of Target/Biomarker

ACEH

Expression platform

Hybridoma

Isotypes

Mouse IgG

Bioactivity validation

Human Human Angiotensin Converting Enzyme 2 (ACE2/hFc) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other Human Angiotensin Converting Enzyme 2 (ACE2/hFc) antibodies in ACE2/hFc level test of Lung injury (acute respiratory distress syndrome) and related syndrome evaluation.

Tag

mFc

Products description

Anti-Human ACE2/hFc mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by hybridoma technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other Human Angiotensin Converting Enzyme 2 (ACE2/hFc) antibodies.

Reconized/Reactive Species

Human

Purity

Purity: ≥95% (SDS-PAGE)

Application

ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT

Formulation

Supplied as a 0.2 μM filtered solution of PBS,PH7.4.

Storage

Store at? -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Diagnostic antibodies and antigens for cancer detection - TG, CA-125, SCC Ag, PIVKA-Ⅱ, ProGRP, Calcitonin, NSE, CA-724, HE4, CA15-3, FER, CYFRA21-1, HER2, HSP90α, S100B, CEA, AFP, sFlt-1, PSA, hEGF, TFF2, TFF3, CA199, CA50, TK1

Regardless of the advances in the cancer therapy, delayed symptoms and lack of successful diagnosis of cancer at early stage increased the death rate. Tumor-associated antigens (TAAs) and their antibodies have been identified as potential markers in cancer diagnosis and determination. TAAs and their antibodies-based detection of cancer have the advantages such as low-cost, and simple access, which attracted much attention for early cancer detection. For several reasons, tumor marker itself is typically insufficient to analyze disease conditions. Because, maximum number of markers have been produced by both normal and cancer cells. Several cancers such as anal, breast, ovaries, testicles, colon, endometrial, peritoneal, fallopian tube, gallbladder, gastric, liver, lung, neuroendocrine, pancreatic, prostate, renal, cervix, stomach and thyroid cancer, bronchopulmonary dysplasia, hepatitis, hematological malignancies, hemochromatosis, hypercalcemia, osteoporosis, Parget’s diseases and so on have been identified using specific marker. Detecting the quantity of marker proteins from different samples may benefit from ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.